📈 stocks · US

BIIB

stocks · US
stocks US ISIN US09062X1037
Overall assessment · Trend now + news, 30 days ?
▲ Strongly bullish strong Confidence 45 % ?
News situation · 1 items / 30 D
▲ Bullish strong 45 %
7.0 Impact / 10
By source type
News 1

No official disclosure in this window — everything below is reporting about BIIB, not from it.

News, 30 days
Bullish
Signal history

Both worlds over time

Technical and news signals of the last 90 days on one timeline.

Bullish ▲Bearish ▼12.09. · News signal · Impact 5/1017.09. · News signal · Impact 7/10
90 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about BIIB

Asset Snapshot

📝 Overview Generated automatically?

BIIB has been the subject of 3 signals across 3 articles in the last 365 days. Sentiment skews Bearish (33%).

Breakdown: 1 bullish, 1 bearish, 1 neutral. AI confidence averages 72% across all signals.

Most-cited catalysts: Alzheimer's tau trial failure published on July 14, 2026 (1×), Biogen's tau therapy fails to meet primary endpoints (1×). Most-cited risk factors: Positive data from other Alzheimer's programs could offset the impact (1×), If the sell-off is viewed as overdone, value buyers might step in (1×).

Keep exploring

Related assets

Same category or comparable signal picture — each card opens the full cockpit.